Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.3.1459

Difference in the Incidences of the Most Prevalent Urologic Cancers from 2003 to 2009 in Iran  

Basiri, Abbas (Department of Urology, Urology and Nephrology Research Center, Shahid Labbafinejad Medical Center, Shahid Beheshti University of Medical Sciences)
Shakhssalim, Nasser (Department of Urology, Urology and Nephrology Research Center, Shahid Labbafinejad Medical Center, Shahid Beheshti University of Medical Sciences)
Jalaly, Niloofar Yahyapour (Department of Urology, Urology and Nephrology Research Center, Shahid Labbafinejad Medical Center, Shahid Beheshti University of Medical Sciences)
Miri, Hamid Heidarian (Department of Epidemiology, Shiraz University of Medical Sciences)
Partovipour, Elham (Cancer Office, Non Communicable Disease Unit, Ministry of Health and Medical Education)
Panahi, Mohammad Hossein (Cancer Office, Non Communicable Disease Unit, Ministry of Health and Medical Education)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.3, 2014 , pp. 1459-1463 More about this Journal
Abstract
Background: Urological cancers represent a major public problem associated with high mortality and morbidity. The pattern of these cancers varies markedly according to era, region and ethnic groups, but increasing incidence trends overall makes focused epidemiological studies important. The aim of the present study was to assess the incidence of most prevalent urological cancers in Iran from 2003 to 2009. Materials and Methods: The data for this study were obtained from the population-based Cancer Registry Center of the Iran Ministry of Health and Medical Education. Differences of mean age and age distributions of each cancer were compared between 2003 and 2009 in men and women. Results: Bladder cancer was the most common urologic cancer in both genders. The rate difference of age standardized ratio (ASR) of bladder and renal cell carcinoma in women were 1.54 and 2.01 percent per 100,000 population from 2003 to the 2009, respectively. In men, the rate difference of age standardized ratio of prostate, testis, kidney and bladder cancer was also 2.23, 1.2, 1.8 and 1.5 percent per 100,000 population from 2003 to 2009, respectively. The mean ages of patients in all cancers in both genders did not differ significantly through time (p value>0.05) but the distribution of ages of patients with bladder and prostate cancer changed significantly from 2003 to 2009 (p value<0.001). Conclusions: The results of present study suggest the general pattern and incidence of urological cancers in Iran are changing, the observed increase pointing to a need for urological cancer screening programs.
Keywords
Urologic cancer; epidemiology; change over time; gender specificity; Iran;
Citations & Related Records
Times Cited By KSCI : 4  (Citation Analysis)
연도 인용수 순위
1 Morrison AS, Buring JE,Verhoek WG, et al (1984). An international study of smoking and bladder cancer. J Urol, 131, 650-4.
2 Panagiotopoulou K, Katsouyanni K, Petridou E, et al (1990). Maternal age, parity, and pregnancy estrogens. Cancer Causes Control, 1, 119-24.   DOI
3 Parkin DM, Bray F, Ferlay J, et al (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108.   DOI   ScienceOn
4 Purdue MP, Devesa SS, Sigurdson AJ, et al (2005). International patterns and trends in testis cancer incidence. Int J Cancer 115, 822-7.   DOI   ScienceOn
5 Qin Q, Xu X, Wang X, et al (2013). Obesity and risk of bladder cancer: a meta-analysis of cohort studies. Asian Pac J Cancer Prev, 14, 3117-21.   과학기술학회마을   DOI   ScienceOn
6 Rohani-Rasaf M, Abdollahi M, Jazayeri S, et al (2013). Correlation of cancer incidence with diet, smoking and socio- economic position across 22 districts of Tehran in 2008. Asian Pac J Cancer Prev, 14, 1669-76.   과학기술학회마을   DOI   ScienceOn
7 Safe S (2002). Environmental estrogens: roles in male reproductive tract problems and in breast cancer. Rev Environ Health, 17, 253-62.
8 Shahar S, Shafurah S, Hasan Shaari NS, et al (2011). Roles of diet, lifetime physical activity and oxidative DNA damage in the occurrence of prostate cancer among men in Klang Valley, Malaysia. Asian Pac J Cancer Prev, 12, 605-11.
9 Shakhssalim N, Hosseini SY, Basiri A, et al (2010). Prominent bladder cancer risk factors in Iran. Asian Pac J Cancer Prev, 11, 601-6.
10 McGlynn KA, Cook MB (2009). Etiologic factors in testicular germ-cell tumors. Future Oncol, 5, 1389-402.   DOI
11 Long XJ, Lin S, Sun YN, Zheng ZF (2012). Diabetes mellitus and prostate cancer risk in Asian countries: a meta-analysis." Asian Pac J Cancer Prev, 13, 4097-100.   과학기술학회마을   DOI   ScienceOn
12 Mathew A, George PS, Ildaphonse G (2009). Obesity and kidney cancer risk in women: a meta-analysis (1992-2008). Asian Pac J Cancer Prev, 10, 471-8.
13 McDavid K, Lee J, Fulton JP, et al (2004). Prostate cancer incidence and mortality rates and trends in the United States and Canada. Public Health Rep, 119, 174-86.
14 McGlynn KA, Devesa SS, Sigurdson AJ, et al (2003). Trends in the incidence of testicular germ cell tumors in the United States. Cancer, 97, 63-70.   DOI   ScienceOn
15 Ministry of Health and Organization (2006). Guideline: National Cancer Registry. Tehran.
16 Moller H, Skakkebaek NE (1996). Risks of testicular cancer and cryptorchidism in relation to socio-economic status and related factors: case-control studies in Denmark. Int J Cancer, 66, 287-93.   DOI
17 Moller H, Skakkebaek NE (1997). Testicular cancer and cryptorchidism in relation to prenatal factors: case-control studies in Denmark. Cancer Causes Control, 8, 904-12.   DOI   ScienceOn
18 Ildaphonse G, George PS, Mathew A (2009). Obesity and kidney cancer risk in men: a meta-analysis (1992-2008). Asian Pac J Cancer Prev, 10, 279-86.
19 Edwards BK, Ward E, Kohler BA, et al (2010). Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer, 116, 544-73.   DOI   ScienceOn
20 Gallus S, Colombo P, Scarpino V, et al (2006). Overweight and obesity in Italian adults 2004, and an overview of trends since 1983. Eur J Clin Nutr, 60, 1174-9.   DOI
21 Gondos A, Bray F, Hakulinen T, et al (2009). Trends in cancer survival in 11 European populations from 1990 to 2009: a model-based analysis. Ann Oncol, 20, 564-73.
22 Jemal A, Siegel R, Ward E, et al (2006). Cancer statistics, 2006. CA Cancer J Clin, 56, 106-30.   DOI   ScienceOn
23 Karim-Kos HE, de Vries E, Soerjomataram I, et al (2008). Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer, 44, 1345-89.   DOI
24 Levi F, Lucchini F, Negri E, et al (2004). Leveling of prostate cancer mortality in Western Europe. Prostate, 60, 46-52.   DOI   ScienceOn
25 Bray F, Lortet-Tieulent J, Ferlay J, et al (2010). Prostate cancer incidence and mortality trends in 37 European countries: an overview. Eur J Cancer, 46, 3040-52.   DOI   ScienceOn
26 Akbari ME, Hosseini SJ, Rezaee A, et al (2008). Incidence of genitourinary cancers in the Islamic Republic of Iran: a survey in 2005. Asian Pac J Cancer Prev, 9, 549-52.
27 Basile S, Angioli R, Manci N, et al (2006). Gynecological cancers in developing countries: the challenge of chemotherapy in low-resources setting. Int J Gynecol Cancer, 16, 1491-7.   DOI
28 Bedwani R, El-Khwsky F, La Vecchia C, et al (1993). Descriptive epidemiology of bladder cancer in Egypt. Int J Cancer, 55, 351-2.   DOI
29 Bray F, Richiardi L, Ekbom A, et al (2006). Trends in testicular cancer incidence and mortality in 22 European countries: continuing increases in incidence and declines in mortality. Int J Cancer, 118, 3099-111.   DOI
30 Brennan P, van der Hel O, Moore LE, et al (2008). Tobacco smoking, body mass index, hypertension, and kidney cancer risk in central and eastern Europe. Br J Cancer, 99, 1912-5.   DOI
31 Cheon J, Kim CS, Lee ES, et al (2002). Survey of incidence of urological cancer in South Korea: a 15-year summary. Int J Urol, 9, 445-54.   DOI   ScienceOn
32 Chu KC, Tarone RE, Freeman HP (2003). Trends in prostate cancer mortality among black men and white men in the United States. Cancer, 97, 1507-16.   DOI
33 Cohen HT, McGovern FJ (2005). Renal-cell carcinoma. N Engl J Med, 353, 2477-90.   DOI   ScienceOn
34 Dieckmann KP, Pichlmeier U (2004). Clinical epidemiology of testicular germ cell tumors. World J Urol, 22, 2-14.   DOI
35 Duncan ME, Goldacre MJ (2011). Mortality trends for benign prostatic hyperplasia and prostate cancer in English populations 1979-2006. BJU Int, 107, 40-5.   DOI
36 Parker SL, Tong T, Bolden S, et al (1997). Cancer statistics, 1997. CA Cancer J Clin, 47, 5-27.   DOI   ScienceOn
37 Siegel R, Naishadham D, Jemal A (2013). Cancer statistics, 2013. CA Cancer J Clin, 63, 11-30.   DOI   ScienceOn
38 Yang XQ, Xu C, Sun Y, Han RF (2013). Diabetes mellitus increases the risk of bladder cancer: an updated meta-analysis. Asian Pac J Cancer Prev, 14, 2583-9.   과학기술학회마을   DOI   ScienceOn
39 Yavari P, Sadrolhefazi B, Mohagheghi MA, et al (2009). A descriptive retrospective study of bladder cancer at a hospital in Iran (1973-2003). Asian Pac J Cancer Prev, 10, 681-4.
40 Moore MA, Eser S, Igisinov N, et al (2010). Cancer epidemiology and control in North-Western and Central Asia - past, present and future. Asian Pac J Cancer Prev, 11, 17-32.
41 World Health Organization (2000). International Classification of diseases for oncology: ICD-O. London.